Search

Your search keyword '"Heim, Dominik A"' showing total 644 results

Search Constraints

Start Over You searched for: Author "Heim, Dominik A" Remove constraint Author: "Heim, Dominik A"
644 results on '"Heim, Dominik A"'

Search Results

1. Towards Interpretable Classification of Leukocytes based on Deep Learning

2. Outlier Detection using Self-Organizing Maps for Automated Blood Cell Analysis

6. Surgical site infections after kidney transplantation are independently associated with graft loss

7. Explainable Artificial Intelligence for Cytological Image Analysis

8. Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis

11. Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous Forum

12. The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality

17. Immunothrombosis of acute care patients quantified with phase imaging flow cytometry

18. Autoencoder Features for Differentiation of Leukocytes Based on Digital Holographic Microscopy (DHM)

22. Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan

23. Pharmacokinetic modeling and simulation with pharmacogenetic insights support the relevance of therapeutic drug monitoring for myeloablative busulfan dosing in adult HSCT.

26. Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies

31. High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation

32. Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study

36. S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.

37. P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

40. Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021.

41. Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV

45. Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation

46. Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed by Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 2 – Pain, Subjective Measures and Safety Analysis

47. Double-Blind, Randomized, Placebo-Controlled Multi-Center Phase III Study Followed By Open-Label Phase on the Efficacy and Tolerability of Budesonide in Patients with Resistant Oral Chronic GVHD: Part 1 - Efficacy Analysis

50. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

Catalog

Books, media, physical & digital resources